SwePub
Sök i LIBRIS databas

  Extended search

WFRF:(Bloem Bastiaan R)
 

Search: WFRF:(Bloem Bastiaan R) > Care of Late-Stage ...

LIBRIS Formathandbok  (Information om MARC21)
FältnamnIndikatorerMetadata
00005881naa a2200637 4500
001oai:lup.lub.lu.se:a0f6f66a-6fd2-4688-856a-004b38661849
003SwePub
008240409s2024 | |||||||||||000 ||eng|
0247 a https://lup.lub.lu.se/record/a0f6f66a-6fd2-4688-856a-004b386618492 URI
0247 a https://doi.org/10.1002/mds.297182 DOI
040 a (SwePub)lu
041 a engb eng
042 9 SwePub
072 7a art2 swepub-publicationtype
072 7a ref2 swepub-contenttype
1001 a Kruse, Christopheru University of Duisburg-Essen4 aut
2451 0a Care of Late-Stage Parkinsonism : Resource Utilization of the Disease in Five European Countries
264 1c 2024
300 a 14 s.
520 a Background: Parkinson's disease (PD) is a neurodegenerative disease that leads to progressive disability. Cost studies have mainly explored the early stages of the disease, whereas late-stage patients are underrepresented. Objective: The aim is to evaluate the resource utilization and costs of PD management in people with late-stage disease. Methods: The Care of Late-Stage Parkinsonism (CLaSP) study collected economic data from patients with late-stage PD and their caregivers in five European countries (France, Germany, the Netherlands, UK, Sweden) in a range of different settings. Patients were eligible to be included if they were in Hoehn and Yahr stage >3 in the on state or Schwab and England stage at 50% or less. In total, 592 patients met the inclusion criteria and provided information on their resource utilization. Costs were calculated from a societal perspective for a 3-month period. A least absolute shrinkage and selection operator approach was utilized to identify the most influential independent variables for explaining and predicting costs. Results: During the 3-month period, the costs were €20,573 (France), €19,959 (Germany), €18,319 (the Netherlands), €25,649 (Sweden), and €12,156 (UK). The main contributors across sites were formal care, hospitalization, and informal care. Gender, age, duration of the disease, Unified Parkinson's Disease Rating Scale 2, the EQ-5D-3L, and the Schwab and England Scale were identified as predictors of costs. Conclusion: Costs in this cohort of individuals with late-stage PD were substantially higher compared to previously published data on individuals living in earlier stages of the disease. Resource utilization in the individual sites differed in part considerably among these three parameters mentioned.
650 7a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicinx Neurologi0 (SwePub)302072 hsv//swe
650 7a MEDICAL AND HEALTH SCIENCESx Clinical Medicinex Neurology0 (SwePub)302072 hsv//eng
653 a cost-of-illness
653 a late-stage parkinsonism
653 a Parkinson's disease
653 a resource utilization
7001 a Lipinski, Annau Philipp University of Marburg,University of Duisburg-Essen4 aut
7001 a Verheyen, Malteu University of Duisburg-Essen4 aut
7001 a Balzer-Geldsetzer, Monikau Philipp University of Marburg,University of Duisburg-Essen4 aut
7001 a Wittenberg, Michaelu Philipp University of Marburg4 aut
7001 a Lorenzl, Stefanu University Hospital Munich,Paracelsus Private Medical University of Salzburg4 aut
7001 a Richinger, Carmenu Paracelsus Private Medical University of Salzburg4 aut
7001 a Schmotz, Christianu Paracelsus Private Medical University of Salzburg4 aut
7001 a Tönges, Larsu St. Josef-Hospital im Katholischen Klinikum Bochum,Ruhr-University Bochum4 aut
7001 a Woitalla, Dirku St. Josef-Krankenhaus Kupferdreh4 aut
7001 a Klebe, Stephanu University Hospital Essen4 aut
7001 a Bloem, Bastiaan R.u Radboud University Medical Center4 aut
7001 a Hommel, Adrianusu Radboud University Medical Center4 aut
7001 a Meissner, Wassilios G.u University of Bordeaux4 aut
7001 a Laurens, Briceu University of Bordeaux4 aut
7001 a Boraud, Thomasu University of Bordeaux4 aut
7001 a Foubert-Samier, Alexandrau University of Bordeaux4 aut
7001 a Vergnet, Sylvainu University of Bordeaux4 aut
7001 a Tison, Françoisu University of Bordeaux4 aut
7001 a Costa, Nadègeu Toulouse University Hospital4 aut
7001 a Odin, Peru Lund University,Lunds universitet,Neurologi, Lund,Sektion IV,Institutionen för kliniska vetenskaper, Lund,Medicinska fakulteten,Restorative Parkinson Unit,Forskargrupper vid Lunds universitet,LU profilområde: Proaktivt åldrande,Lunds universitets profilområden,Neurology, Lund,Section IV,Department of Clinical Sciences, Lund,Faculty of Medicine,Lund University Research Groups,LU Profile Area: Proactive Ageing,Lund University Profile areas4 aut0 (Swepub:lu)med-poi
7001 a Rosqvist, Kristinau Lund University,Lunds universitet,Neurologi, Lund,Sektion IV,Institutionen för kliniska vetenskaper, Lund,Medicinska fakulteten,Restorative Parkinson Unit,Forskargrupper vid Lunds universitet,Neurology, Lund,Section IV,Department of Clinical Sciences, Lund,Faculty of Medicine,Lund University Research Groups4 aut0 (Swepub:lu)med-krq
7001 a Norlin, Jenny M.u IHE – The Swedish Institute for Health Economics4 aut
7001 a Hjalte, Fridau IHE – The Swedish Institute for Health Economics4 aut
7001 a Schrag, Anetteu University College London4 aut
7001 a Dodel, Richardu Philipp University of Marburg,University of Duisburg-Essen4 aut
7102 a University of Duisburg-Essenb Philipp University of Marburg4 org
7730 t Movement Disordersg 39:3, s. 571-584q 39:3<571-584x 0885-3185
8564 u http://dx.doi.org/10.1002/mds.29718x freey FULLTEXT
8564 8u https://lup.lub.lu.se/record/a0f6f66a-6fd2-4688-856a-004b38661849
8564 8u https://doi.org/10.1002/mds.29718

Find in a library

To the university's database

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view